|4Mar 21, 6:03 PM ET

Apuli Maricel 4

4 · BridgeBio Pharma, Inc. · Filed Mar 21, 2025

Insider Transaction Report

Form 4
Period: 2025-03-19
Apuli Maricel
Chief Accounting Officer
Transactions
  • Award

    Common Stock

    2025-03-19+23,660148,665 total
Footnotes (2)
  • [F1]Grant of restricted stock units ("RSUs") under the Issuer's 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan. The RSUs shall vest with respect to 1/16th of the underlying shares on May 16, 2025, and as to 1/16th of the underlying shares each quarter thereafter until fully vested, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.
  • [F2]Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4